Growth Metrics

Zoetis (ZTS) EBITDA: 2012-2025

Historic EBITDA for Zoetis (ZTS) over the last 14 years, with Sep 2025 value amounting to $964.0 million.

  • Zoetis' EBITDA rose 0.73% to $964.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 6.79%. This contributed to the annual value of $3.5 billion for FY2024, which is 10.03% up from last year.
  • Per Zoetis' latest filing, its EBITDA stood at $964.0 million for Q3 2025, which was down 5.68% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Zoetis' EBITDA registered a high of $1.0 billion during Q2 2025, and its lowest value of -$131.0 million during Q1 2021.
  • For the 3-year period, Zoetis' EBITDA averaged around $866.0 million, with its median value being $863.0 million (2023).
  • As far as peak fluctuations go, Zoetis' EBITDA slumped by 126.52% in 2021, and later spiked by 732.06% in 2022.
  • Quarterly analysis of 5 years shows Zoetis' EBITDA stood at $632.0 million in 2021, then rose by 15.19% to $728.0 million in 2022, then increased by 2.34% to $745.0 million in 2023, then rose by 7.65% to $802.0 million in 2024, then increased by 0.73% to $964.0 million in 2025.
  • Its EBITDA stands at $964.0 million for Q3 2025, versus $1.0 billion for Q2 2025 and $878.0 million for Q1 2025.